809
Participants
Start Date
November 30, 2013
Primary Completion Date
October 31, 2014
Study Completion Date
November 30, 2014
olodaterol
fixed dose combination
tiotropium
fixed dose combination
placebo
1237.26.10620 Boehringer Ingelheim Investigational Site, Jasper
1237.26.10618 Boehringer Ingelheim Investigational Site, Stamford
1237.26.10619 Boehringer Ingelheim Investigational Site, Clearwater
1237.26.10614 Boehringer Ingelheim Investigational Site, Tampa
1237.26.10616 Boehringer Ingelheim Investigational Site, Duluth
1237.26.10613 Boehringer Ingelheim Investigational Site, St Louis
1237.26.10615 Boehringer Ingelheim Investigational Site, Greensboro
1237.26.10603 Boehringer Ingelheim Investigational Site, Columbus
1237.26.10621 Boehringer Ingelheim Investigational Site, Dayton
1237.26.10612 Boehringer Ingelheim Investigational Site, Toledo
1237.26.10605 Boehringer Ingelheim Investigational Site, Oklahoma City
1237.26.10606 Boehringer Ingelheim Investigational Site, Medford
1237.26.10610 Boehringer Ingelheim Investigational Site, East Providence
1237.26.10607 Boehringer Ingelheim Investigational Site, Gaffney
1237.26.10617 Boehringer Ingelheim Investigational Site, Greenville
1237.26.10608 Boehringer Ingelheim Investigational Site, Spartanburg
1237.26.10604 Boehringer Ingelheim Investigational Site, Union
1237.26.10609 Boehringer Ingelheim Investigational Site, Boerne
1237.26.10602 Boehringer Ingelheim Investigational Site, San Antonio
1237.26.10601 Boehringer Ingelheim Investigational Site, Morgantown
1237.26.61004 Boehringer Ingelheim Investigational Site, Concord
1237.26.61002 Boehringer Ingelheim Investigational Site, Daw Park
1237.26.61003 Boehringer Ingelheim Investigational Site, Toorak Gardens
1237.26.61007 Boehringer Ingelheim Investigational Site, Woodville
1237.26.61005 Boehringer Ingelheim Investigational Site, Murdoch
1237.26.61001 Boehringer Ingelheim Investigational Site, Nedlands
1237.26.43004 Boehringer Ingelheim Investigational Site, Feldbach
1237.26.43002 Boehringer Ingelheim Investigational Site, Grieskirchen
1237.26.43003 Boehringer Ingelheim Investigational Site, Linz
1237.26.43006 Boehringer Ingelheim Investigational Site, Linz
1237.26.43001 Boehringer Ingelheim Investigational Site, Thalheim bei Wels
1237.26.11605 Boehringer Ingelheim Investigational Site, Moncton
1237.26.11609 Boehringer Ingelheim Investigational Site, Courtice
1237.26.11608 Boehringer Ingelheim Investigational Site, Sarnia
1237.26.11606 Boehringer Ingelheim Investigational Site, Toronto
1237.26.11607 Boehringer Ingelheim Investigational Site, Toronto
1237.26.11601 Boehringer Ingelheim Investigational Site, Windsor
1237.26.11611 Boehringer Ingelheim Investigational Site, Mirabel
1237.26.11602 Boehringer Ingelheim Investigational Site, Point Claire
1237.26.11603 Boehringer Ingelheim Investigational Site, Sherbrooke
1237.26.49610 Boehringer Ingelheim Investigational Site, Bamberg
1237.26.49611 Boehringer Ingelheim Investigational Site, Berlin
1237.26.49616 Boehringer Ingelheim Investigational Site, Berlin
1237.26.49609 Boehringer Ingelheim Investigational Site, Bochum
1237.26.49607 Boehringer Ingelheim Investigational Site, Dresden
1237.26.49612 Boehringer Ingelheim Investigational Site, Frankfurt
1237.26.49615 Boehringer Ingelheim Investigational Site, Halberstadt
1237.26.49606 Boehringer Ingelheim Investigational Site, Hamburg
1237.26.49608 Boehringer Ingelheim Investigational Site, Hanover
1237.26.49603 Boehringer Ingelheim Investigational Site, Hettstedt
1237.26.49604 Boehringer Ingelheim Investigational Site, Leipzig
1237.26.49605 Boehringer Ingelheim Investigational Site, Leipzig
1237.26.49601 Boehringer Ingelheim Investigational Site, Lübeck
1237.26.49602 Boehringer Ingelheim Investigational Site, Rüdersdorf
1237.26.49614 Boehringer Ingelheim Investigational Site, Schwerin
1237.26.49613 Boehringer Ingelheim Investigational Site, Wiesloch
1237.26.30005 Boehringer Ingelheim Investigational Site, Athens
1237.26.30002 Boehringer Ingelheim Investigational Site, Heraklion
1237.26.30001 Boehringer Ingelheim Investigational Site, Nafplion
1237.26.30004 Boehringer Ingelheim Investigational Site, Serres
1237.26.30003 Boehringer Ingelheim Investigational Site, Thessaloniki
1237.26.64001 Boehringer Ingelheim Investigational Site, Greenlane East Auckland NZ
1237.26.47003 Boehringer Ingelheim Investigational Site, Hamar
1237.26.47001 Boehringer Ingelheim Investigational Site, Hønefoss
1237.26.47002 Boehringer Ingelheim Investigational Site, Kløfta
1237.26.47004 Boehringer Ingelheim Investigational Site, Lierskogen
1237.26.42103 Boehringer Ingelheim Investigational Site, Bardejov
1237.26.42104 Boehringer Ingelheim Investigational Site, Humenné
1237.26.42102 Boehringer Ingelheim Investigational Site, Spišská Nová Ves
1237.26.42101 Boehringer Ingelheim Investigational Site, Vyšné Hágy
1237.26.27601 Boehringer Ingelheim Investigational Site, Cape Town
1237.26.27602 Boehringer Ingelheim Investigational Site, Cape Town
1237.26.27604 Boehringer Ingelheim Investigational Site, Cape Town
1237.26.27605 Boehringer Ingelheim Investigational Site, Durban
1237.26.46004 Boehringer Ingelheim Investigational Site, Höllviken
1237.26.46001 Boehringer Ingelheim Investigational Site, Lund
1237.26.46002 Boehringer Ingelheim Investigational Site, Stockholm
1237.26.46003 Boehringer Ingelheim Investigational Site, Uddevalla
Lead Sponsor
Boehringer Ingelheim
INDUSTRY